Experimental studies in T2DM suggested an improvement in insulin resistance and a suppression of hepatic gluconeogenesis and fasting hyperglycemia in animals receiving leptin replacement therapy [109]. This evidence concerns the gene LEP and type 2 diabetes mellitus.